Matthew Kaplan

Entity
Individual
Business address
C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275, 07024 Fort Lee, NJ
Signature Ownership
/s/ Matthew Kaplan
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Matthew Kaplan has filed 6 SEC EDGAR filings since 2/8/2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT Jun 12, 2025 Jun 12, 2025 001-41264
4 Open Document Open Filing OWNERSHIP DOCUMENT Jun 13, 2024 Jun 13, 2024 001-41264
4 Open Document Open Filing OWNERSHIP DOCUMENT Jun 20, 2023 Jun 16, 2023 001-41264
4 Open Document Open Filing OWNERSHIP DOCUMENT May 16, 2022 May 12, 2022 001-41264
4 Open Document Open Filing OWNERSHIP DOCUMENT Apr 5, 2022 Apr 1, 2022 001-41264
3 Open Document Open Filing OWNERSHIP DOCUMENT Feb 8, 2022 Feb 8, 2022 001-41264